Global Dialysis

Dialysis industry news

Stories from the dialysis comunity across the globe.

Cefepime:Label Change- Risk of Seizure in Patients Not Receiving ... - Healthcare Packaging

Audience: Health Professional,Infectious Disease, Nephrology

Issue: There have been cases of a specific type of seizure called nonconvulsive status epilepticus associated with the use of cefepime, primarily in patients with renal impairment who did not receive appropriate dosage adjustments of cefepime. The Warnings and Precautions and Adverse Reactions sections of the cefepime label are being revised to highlight this risk.

Background:Cases of nonconvulsive status epilepticus associated with cefepime are documented in the medical literature and have been identified in FDA’s Adverse Event Reporting System (AERS) database. Most cases occurred in patients with renal impairment who did not receive appropriate dosage adjustment; however, some cases occurred in patients receiving dosage adjustment appropriate for their degree of renal impairment. In the majority of cases, the seizures were reversible and resolved after discontinuing cefepime and/or after hemodialysis. See the Drug Safety Communication for additional information.

Recommendations: Health care professionals should adjust the dosage of cefepime in patients with creatinine clearance less than or equal to 60 mL/min. If seizures associated with cefepime therapy occur, consider discontinuing cefepime or making appropriate dosage adjustments in patients with renal impairment.

Caregivers who notice symptoms of nonconvulsive status epilepticus in a patient receiving cefepime should seek medical attention right away. Symptoms of nonconvulsive status epilepticus could include altered mental status, confusion, and decreased responsiveness.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Complete and submit the report Online.
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

...

Big Red Bus dream gains momentum - Latrobe Valley Express

AN ambitious project allowing kidney dialysis patients the opportunity to go on holiday is likely to see a world-first mobile satellite unit established in the Latrobe Valley.

The Big Red Kidney Bus project, spearheaded by dialysis patient Vince Tripodi who died in February, has steadily gathered momentum, attracting donations and widespread support.

A local team is now committed to seeing Vince's dream of having the dialysis bus on the road by the end of the year, become a reality.

Past weeks have been significant for the team of Latrobe Regional Hospital dialysis patients and staff, Kidney Health Australia staff and Vince's family, who remain devoted to the cause and recently accepted an award on their father's behalf.

Vince's son Marco told The Express the award, presented by KHA and received by himself, his mother and two sisters, was a "fantastic honour".

He said his father was aware he was to be recognised formally for his work in leading the Big Red Kidney Bus campaign but "he wasn't overly impressed because he figured he hadn't done anything yet because it wasn't finished".

"It has been a fantastic achievement though," Marco said, of the project which has so far raised $25,000 towards fitting out a bus which it secured, via donation, from Grenada.

Latrobe Valley Bus Lines has also offered drivers for the bus, while multiple local organisations have donated goods in kind to help equip it.

About $100,000 is required to renovate the bus to hospital standards, which will then be staffed with nurses and positioned in holiday locations across Victoria.

Renal patient and active committee member Suzie Picken, together with dialysis unit nurse Bernardette Lewindon, recently presented a paper on the bus project to the Renal Society Australasian Conference 2012 and predicted "once this is operational it's going to be a world first".

"I believe there are other buses out there now but none are staffed and this would be the first staffed satellite unit of its kind," she said.

...

Groundbreaking Held On New BH Dialysis Center - WSJM

On Tuesday, a groundbreaking was held on a new 87 hundred square foot dialysis treatment center in Benton Harbor. Officials from Liberty Dialysis, Lakeland HealthCare, and Lake Michigan Nephrology broke ground on the one point eight million dollar project. Lake Michigan Nephrology's Doctor Katie Kwon says the new center will mean a lot for kidney patients in the area:

The new center is a partnership between Lakeland HealthCare, Lake Michigan Nephrology, and Liberty Dialysis, which is an organization that has a history of developing clinics in underserved communities with the help of local doctors and non profits.

WebReady^TM Powered by WireReady^® NSI

...

Research and Markets: Belgium Nephrology and Urology Devices ... - Business Wire (press release)

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ktd26b/belgium_nephrology) has announced the addition of GlobalData's new report "Belgium Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters" to their offering.

“Belgium Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters”

GlobalData's new report, Belgium Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters provides key market data on the Belgium Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope:

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the Belgium Nephrology and Urology Devicesmarket.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Belgium Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

Companies Mentioned:

- Fresenius Medical Care AG & Co. KGaA

- Svenska Cellulosa Aktiebolaget SCA

- Baxter International Inc.

- HARTMANN GROUP

- ONTEX International N.V.

- Astra Tech Inc.

- Coloplast AS

- B. Braun Melsungen AG

- Kimberly-Clark Corporation

- First Quality Enterprises, Inc.

- Covidien plc

- Medline Industries, Inc.

- Siemens Healthcare

- Dornier MedTech GmbH

- Gambro AB

- Asahi Kasei Corporation

- NIPRO CORPORATION

For more information visit http://www.researchandmarkets.com/research/ktd26b/belgium_nephrology

Source: GlobalData

...

Research and Markets: Belgium Nephrology and Urology Devices Market ... - Business Wire (press release)

“Belgium Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters”

Scope:

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the Belgium Nephrology and Urology Devicesmarket.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Belgium Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

Companies Mentioned:

- Fresenius Medical Care AG & Co. KGaA

- Svenska Cellulosa Aktiebolaget SCA

- Baxter International Inc.

- HARTMANN GROUP

- ONTEX International N.V.

- Astra Tech Inc.

- Coloplast AS

- B. Braun Melsungen AG

- Kimberly-Clark Corporation

- First Quality Enterprises, Inc.

- Covidien plc

- Medline Industries, Inc.

- Siemens Healthcare

- Dornier MedTech GmbH

- Gambro AB

- Asahi Kasei Corporation

- NIPRO CORPORATION

For more information visit http://www.researchandmarkets.com/research/ktd26b/belgium_nephrology

Source: GlobalData

...

More Articles...

<< Start < Prev 511 512 513 514 515 516 517 518 519 520 Next > End >>

Page 520 of 4210

Share |

Empowering dialysis users and caregivers

Search for dialysis centres here

Jobs in dialysis

Dialysis travel

Dialysis information

Translate Global Dialysis

Dialysis centre search LOGIN HERE

Resources